EVP, Chief Commercial Officer of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Neumann Mark, sells 5,184 shares worth $203,308
According to Intra-Cellular Therapies, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 22 08:07 PM, company EVP, Chief Commercial Officer, Neumann Mark disclosed selling 5,184 shares at a cost of $39.22. At the time of this transaction (Feb 19), this trade was worth $203,308 in total. As of Feb 19, Neumann Mark now owns 45,339 shares in total worth about $1,766,860.8299999998.
For the last few recent trades made by Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) EVP, Chief Commercial Officer, Neumann Mark, we have the following information:
- SEC Form 4 filing: Jan 11: Sold 9,684 shares at the rate of $32.02 per share. Total worth of this trade was $310,082. Total number of shares owned as of Jan 11 were 39,384
- SEC Form 4 filing: Oct 16: Sold 6,792 shares at the rate of $26.80 per share. Total worth of this trade was $182,026. Total number of shares owned as of Oct 16 were 28,120
- SEC Form 4 filing: Oct 16: Sold 6,774 shares at the rate of $8.25 per share. Total worth of this trade was $55,886. Total number of shares owned as of Oct 16 were 6,674
Posted by
George Daniels
on Monday February 22 2021, 11:56 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
